Comparison of clinical primary tumor site (PTS) response to induction chemotherapy (IC) with APF (<i>nab-</i>paclitaxel, cisplatin, and 5-FU) or APF plus cetuximab (APF+Cetux) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).Jessica Ley, Douglas R. Adkins, Jason Diaz et al.|Journal of Clinical Oncology|2014Cited by 2